13 research outputs found
Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection
This work was supported by ARUK project grant 21210 ‘Sustained and Controllable Local Delivery of Anti-inflammatory Therapeutics with Nanoengineered Microcapsules’. The work was also supported in part by Russian Foundation of Basic Research grants No. 16-33-50153 mol_nr, No. 16-33-00966 mol_a, Russian Science Foundation grant No. 15-15-00170 and Russian Governmental Program ‘‘Nauka’’, No. 1.1658.2016, 4002
Human neutral brush border endopeptidase EC 3.4.24.11 in urine, its isolation, characterisation and activity in renal diseases
Human neutral brush border endopeptidase (NEP) was purified from the
urine of patients suffering from acute toxic tubulointerstitial
nephropathy. An enzyme preparation with specific activity of 102 Ug(-1)
protein was obtained. The urinary activities of neutral endopeptidase
and alanine aminopeptidase were measured in patients with renal disease
and in 30 control patients, resulting in a reference range from 0.1 to
0.7 Ug(-1) creatinine and 1.4-14.1 Ug(-1) creatinine, respectively.
Urine enzyme activities were highest in patients with acute tubulotoxic
renal diseases. Neutral endopeptidase and alanine aminopeptidase
activities were found to be 6.5- and 10-fold higher than the upper value
of the reference range, respectively. Smaller increases in the rate of
excretion of these enzymes (2.5- and 3.5-fold), respectively, were
observed in patients suffering from acute tubular insufficiency and even
lower increases, 2- and 1.5-fold, respectively, were observed in
patients with chronic renal diseases. In diabetics and kidney transplant
patients the enzyme excretion rates were within the reference range.
Assay of both transmembrane metalloproteinases in urine may prove
valuable in serving as markers for renal toxicity. Together with
beta-NAG these enzymes could be employed as differentiation markers
between acute and chronic tubular insufficiency. (C) 2000 Elsevier
Science B.V. All rights reserved
Magnetic nanoparticle formulations for DNA and siRNA delivery.
Newly synthesized magnetic nanomaterials possess high DNA binding capacity either itself or in the presence of a positively charged lipid-based Metafectene™ reagent or branched polyethylene imine 25 kDa. Polyethylene imine (PEI)-modified nanomaterials are able to deliver nucleic acids in cell culture in duplexes. Magnetofection with triplexes of nanomaterials results in higher transduction efficiencies compared to optimal PEI or Metafectene formulations. 90% transient down-regulation of the target protein in HeLa-green fluorescence protein cells was achieved at short interfering RNA concentrations as low as 8 nM with a formulation of PEI-modified nanoparticles
Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC.
The anatomical location and extent of primary lung tumors have shown prognostic value for overall survival (OS). However, its manual assessment is prone to interobserver variability. This study aims to use data driven identification of image characteristics for OS in locally advanced non-small cell lung cancer (NSCLC) patients. Five stage IIIA/IIIB NSCLC patient cohorts were retrospectively collected. Patients were treated either with radiochemotherapy (RCT): RCT1* (n = 107), RCT2 (n = 95), RCT3 (n = 37) or with surgery combined with radiotherapy or chemotherapy: S1* (n = 135), S2 (n = 55). Based on a deformable image registration (MIM Vista, 6.9.2.), an in-house developed software transferred each primary tumor to the CT scan of a reference patient while maintaining the original tumor shape. A frequency-weighted cumulative status map was created for both exploratory cohorts (indicated with an asterisk), where the spatial extent of the tumor was uni-labeled with 2 years OS. For the exploratory cohorts, a permutation test with random assignment of patient status was performed to identify regions with statistically significant worse OS, referred to as decreased survival areas (DSA). The minimal Euclidean distance between primary tumor to DSA was extracted from the independent cohorts (negative distance in case of overlap). To account for the tumor volume, the distance was scaled with the radius of the volume-equivalent sphere. For the S1 cohort, DSA were located at the right main bronchus whereas for the RCT1 cohort they further extended in cranio-caudal direction. In the independent cohorts, the model based on distance to DSA achieved performance: AUC <sub>RCT2</sub> [95% CI] = 0.67 [0.55-0.78] and AUC <sub>RCT3</sub> = 0.59 [0.39-0.79] for RCT patients, but showed bad performance for surgery cohort (AUC <sub>S2</sub> = 0.52 [0.30-0.74]). Shorter distance to DSA was associated with worse outcome (p = 0.0074). In conclusion, this explanatory analysis quantifies the value of primary tumor location for OS prediction based on cumulative status maps. Shorter distance of primary tumor to a high-risk region was associated with worse prognosis in the RCT cohort